Kalymin retard

Medicinal product

(Invented) name

Kalymin retard

Active substance (s)

Piridostigmino bromidas

Strength

180 mg

Pharmaceutical form

pailginto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N07AA02, Pyridostigmine

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2023-03-01

Date of renewal

Documents

1840_Kalymin retard_2023-03-01.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Piridostigmino bromidas	180 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
110472	96582	1096582	buteliukas	N50		Receptinis	LT/L/23/1840/001	Tiekiama	-	-	No	-	-	Download
110473	96583	1096583	buteliukas	N100		Receptinis	LT/L/23/1840/002	Netiekiama	2024-12-16	2025-06-30	Yes	2025-01-01	2025-06-30

Stadijos

Data	Stadija
2023-03-01	Registruotas